https://www.selleckchem.com/pr....oducts/gsk-lsd1-2hcl
Aspirin has recently emerged as an anticancer drug, but its therapeutic effect on lung cancer has been rarely reported, and the mechanism of action is still unclear. Long-term use of celecoxib in large doses causes serious side effects, and it is necessary to explore better ways to achieve curative effects. In this study, we evaluated the synergistic anticancer effects of celecoxib and aspirin in non-small cell lung cancer (NSCLC) cells. , we evaluated the combined effects of celecoxib (40 μM) and aspirin (8 mM) on cell apoptosis,
Like
Comment
Share
